Aims This study examines the effect of ovarian function on thromboxane A 2 (TXA 2 ), prostaglandin (PG) I 2 , PGF 2a , and PGE 2 release as well as the role of these substances in nitric oxide (NO) release and acetylcholine (ACh)-mediated relaxation. Methods and results Aortic segments from ovariectomized and control female Sprague-Dawley rats were used. Cyclooxygenase (COX-1 and COX-2) expression was studied. ACh-induced relaxation was analysed in the absence and presence of the COX-2 inhibitor NS-398, the TXA 2 synthesis inhibitor furegrelate, the PGI 2 synthesis inhibitor tranylcypromine (TCP), or the thromboxane-prostanoid receptor antagonist SQ-29548. TXA 2 , PGI 2 , PGF 2a , and PGE 2 release was measured, and the vasomotor effect of exogenous TXA 2 , PGI 2, PGF 2a , and PGE 2 was assessed. Basal and ACh-induced NO release in the absence and presence of NS-398, furegrelate, TCP, or TCP plus furegrelate was studied. Ovariectomy did not alter or increased COX-1 or COX-2 expression, respectively. NS-398 decreased, and furegrelate did not change, the ACh-induced relaxation in arteries from both groups. SQ29,548 decreased the AChinduced relaxation only in aortas from ovariectomized rats. TCP decreased the ACh-induced relaxation in both groups, and furegrelate or SQ29,548 totally restored that response only in aortas from control rats. Ovariectomy increased the ACh-induced TXA 2 , PGI 2 , and PGE 2 release and the contractile responses induced by exogenous TXA 2 , PGF 2a , or PGE 2 , while it decreased the PGI 2 -induced vasodilator response. In aortas from control rats, NS-398 did not alter the ACh-induced NO release, and furegrelate, TCP, or TCP plus furegrelate increased that release. In arteries from ovariectomized rats, NS-398, furegrelate, TCP, or TCP plus furegrelate decreased the ACh-induced NO release. Conclusion Despite the prevalence of vasoconstrictor prostanoids derived from COX-2 in aortas from ovariectomized rats, the ACh-induced relaxation is maintained, probably as consequence of the positive regulation that prostanoids exert on eNOS activity.
Introduction
Vascular tone is regulated by several mechanisms in which nitric oxide (NO) and prostanoids are pivotal factors. NO produces relaxation by stimulating the soluble guanylate cyclase, which increases the intracellular levels of cGMP in the smooth muscle cells of the arterial wall. 1, 2 Prostanoids are generated by arachidonic acid metabolism through the cyclooxygenase (COX) pathway. [3] [4] [5] One of the best studied prostanoids is thromboxane A 2 (TXA 2 ), which has been implicated as a mediator in diseases such as myocardial infarction and hypertension. 6, 7 Additionally, the role of COX derivatives other than TXA 2 , such as prostaglandin (PG) F 2a and PGE 2 , or PGI 2 which can induce a vasoconstrictor or vasodilator response is the subject of numerous studies, 5, [8] [9] [10] since they could also participate in vascular dysfunction.
On the other hand, although NO has been reported to modulate prostanoid production, 11, 12 there have been few reports on the action of prostanoids modulating NO release. 13, 14 Recently, we reported that endogenous TXA 2 regulates neuronal NO release from mesenteric arteries. 15 However, details about the action of endogenous prostanoids on endothelial NO release in vascular tissue are scarcely known.
Clinical and epidemiological studies have indicated the existence of gender differences in vascular function and that there is an increased prevalence of cardiovascular diseases in postmenopausal women. 16 Taking into account that women spend more than a third of their life time in postmenopause, to know the possible alterations in the cellular mechanisms that participate in vascular tone regulation in this particular condition is of enormous health relevance. We have previously demonstrated that the loss of ovarian function increased superoxide anion production in rat aorta, but did not affect either endothelial NO synthase (eNOS) expression or NO release. 17 However, there are no studies analysing how the loss of ovarian function influences the involvement of prostanoids on cardiovascular function. In view of these data and taking into account that endogenous male sex hormones modulate the formation and function of prostanoids, 18 as well as the effect of TXA 2 on neuronal NO release, 15 it is plausible to speculate that the loss of ovarian function may alter the production of COX derivatives and their role in the endothelial NO release. For this purpose, the expression of COX-1 and COX-2, the production and the vasomotor effect of the prostanoids TXA 2 , PGI 2 , PGF 2a , and PGE 2 , the involvement of these prostanoids in NO release and ultimately in the acetylcholine (ACh)-induced response were analysed in aortas from female rats with intact (control) or removed (ovariectomized) ovaries.
Methods

Animal housing and protocols
Female Sprague-Dawley rats (6 months old) were divided into two groups: control (in oestrus phase) and ovariectomized rats. All animals were housed in the Animal Facility of the Universidad Autónoma de Madrid (Registration number EX-021U) according to directives 609/86 CEE and R.D. 233/88 of the Ministerio de Agricultura, Pesca y Alimentación of Spain. Bilateral ovariectomy was induced at 4 weeks of age, and 5 months later the animals were sacrificed. The observation of uterus atrophy confirmed the effectiveness of ovariectomy. The oestrus stage was determined by microscopic evaluation of a vaginal smear taken before the animals were sacrificed. Rats were sacrificed by CO 2 inhalation; the thoracic aorta was carefully dissected out, cleaned of connective tissue, cut into 4 mm long and placed in Krebs-Henseleit solution (KHS) containing, in mmol/L: NaCl 115, CaCl 2 2.5, KCl 4.6, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 25, glucose 11.1, Na 2 EDTA 0.03 at 48C. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85. 23 revised 1985) . This study was also approved by the Ethical Committee of the Universidad Autónoma of Madrid.
Systolic blood pressure
Systolic blood pressure was indirectly measured in awake animals by the tail-cuff method 19 (Letica, Digital Pressure Meter, LE5000, Barcelona, Spain).
Western blot analysis of COX-1 and COX-2
Aortic segments were homogenized, proteins electrophoretically separated and transferred to polyvinyl difluoride membranes (BioRad Immun-Blot w ). 18 Membranes were incubated with antibodies against COX-1 (1:500 dilution, Cayman Chemical), COX-2 (1:200 dilution, Cayman Chemical), or actin (1:3000 dilution, Sigma) proteins and individual horseradish peroxidase-conjugated secondary antibodies in blocking buffer. Immunoreactive proteins were detected by chemiluminescence with ECL Plus (ECL Plus, Amersham International Plc, Little Chalfont, UK).
Vascular reactivity
Two parallel stainless steel pins were introduced through the lumen of the vascular segment: one was fixed to the bath wall and the other connected to a force transducer (Grass FTO3C; Grass Instruments Co., Quincy, MA, USA); this in turn was connected to a model 7D Grass polygraph. 20 The segments, maintained in KHS at 378C and pH 7.4, were subjected to a tension of 1 g which was readjusted every 15 min during a 60 min equilibration period before drug administration. Then, vessels were exposed to KCl (75 mmol/L) to check the functional integrity. After a washout period, the presence of vascular endothelium was confirmed by the ability of 10 mmol/L ACh to relax segments precontracted with 1 mmol/L 5-hydroxytryptamine (5-HT). The segments were rinsed with KHS for 1 h, and then a cumulative ACh concentrationresponse curve (0.1 nmol/L to 10 mmol/L) was obtained in 5-HT precontracted segments.
To investigate the participation of prostanoids derived from COX-2 in the ACh-induced response, some aortic segments were incubated with the COX-2 inhibitor (NS-398, 10 mmol/L), the TXA 2 synthase inhibitor (furegrelate, 1 mmol/L), the TXA 2 -prostanoid (TP) receptor antagonist (SQ29,548, 1 mmol/L), the PGI 2 synthase inhibitor, (tranylcypromine: TCP, 10 mmol/L), TCP plus furegrelate or TCP plus SQ29,548, for 30 min before generating the ACh concentrationresponse curve. To evaluate properly the effect of the inhibitors/ blockers on the ACh-induced response, and because application of several consecutive full concentration-response curve to ACh caused a reduction in its vasodilator effect (unpublished results), only one cumulative ACh concentration curve was performed in each aortic segment.
To assess possible differences in the responses induced by TXA 2 , PGI 2 , PGF 2a , or PGE 2 in arteries from both groups, concentrationresponse curves for the TXA 2 mimetic (15)-hydroxy-11a, 9 a-(epoxymethano)prosta-5,13-dienoic acid (U-46619, 1 nmol/L to 10 mmol/L), exogenous PGI 2 
(1 nmol/L to 10 mmol/L) were performed in arteries from control and ovariectomized rats.
Prostanoids production
The production of TXA 2, PGI 2 , PGF 2a , and PGE 2 in vivo was monitored by measuring the stable metabolite TXB 2 , 6-keto-PGF 1a , 13,14-dihydro-15-keto PGF 2a , and PGE 2 , respectively, using the respective enzyme immunoassay kit (Cayman Chemical). 18 The stabilization period (30 min in KHS at 378C, pH 7.4) was followed by two washout periods of 10 min in a bath of 0.2 mL of KHS, after which arteries were subjected to 1 mmol/L 5-HT for 2 min and then ACh concentration curve (0.1 nmol/L to 10 mmol/L) was applied at 1 min interval and the medium was collected to perform the assay. The different assays were carried out according to the manufacturer's instructions. Results were expressed as pg prostanoid/mL mg tissue. 21 Then, the medium was collected to measure the basal and the ACh-induced (0.1 nmol/L to 10 mmol/L) NO release. The fluorescence was measured in a spectrofluorimeter (LS50 Perkin Elmer instruments, FL WINLAB Software) with excitation wavelength set at 495 nm and emission wavelength at 515 nm. Although DAF-2 is widely used as detector for NO, it can also react with intermediate products of the oxidation of NO. Therefore, some assays were performed in the presence of the NO synthesis inhibitor L-NAME, in which the ACh-induced fluorescence was abolished, 22 indicating that ACh-induced eNOS-derived NO release.
NO release
The interference of endogenous prostanoids on NO release was studied by incubating the segments 30 min before collecting medium with NS-398 (10 mmol/L), furegrelate (1 mmol/L), TCP (10 mmol/L), or the combination of furegrelate plus TCP.
Blank measures were collected in the same way from segment-free medium in order to subtract background emission. The amount of NO released was expressed as arbitrary units/mg tissue.
Drugs
5-HT, ACh chloride, DAF-2, furegrelate, TCP, PGI 2 , and PGF 2a (Sigma-Aldrich); PGE 2 (Cayman Chemical), U-46619 and NS-398 (Calbiochem), and SQ29,548 (Biolink, SL). Stock solutions (10 mmol/L) of drugs were prepared in distilled water, except for SQ29,548, U-46619, and PGE 2 which were dissolved in ethanol and administered from a prepared stock in such a way that the maximal ethanol concentration in the medium was less than 0.001% (vol/ vol). All these solutions were stored at 2208C and appropriate dilutions were made in KHS, or HEPES, on the day of the experiment.
Statistical analysis
Results are given as mean + SEM. The responses elicited by KCl were expressed in mg and those elicited by U-46619 and PGE 2 were expressed as percentage of the tone induced by 75 mmol/L KCl. The relaxation induced by ACh and PGI 2 was expressed as a percentage of the initial contraction elicited by 5-HT. Statistical analysis was done by comparing the curve obtained in the presence of the different substances with the control curve by means of two-way analysis of variance (ANOVA). When ANOVA showed a significant treatment effect, Bonferroni post hoc test was used to compare individual means. The maximum response (E max value) and the logarithm of the ACh concentration producing 50% of maximum response (log EC 50 ) were calculated by a non-linear regression analysis of each individual concentration-response curve using Graph Pad Prism Software (San Diego, CA, USA) and the statistical analysis was done using unpaired Student's t-test. For prostanoid and NO release experiments, the statistical analysis Student's t-test. A P-value of less than 0.05 was considered significant.
Results
Animal model
Ovariectomy decreased the uterus weight (control: 1.13 + 0.06; ovariectomized: 0.16 + 0.04; n ¼ 10; P , 0.001), which is an index of the lost of ovarian function. Ovariectomy increased the body weight (control: 257.7 + 10.4; ovariectomized: 374.6 + 4.9; P , 0.001), as previously reported. 23 Ovariectomy did not modify the systolic blood pressure (control: 121.5 + 3.5 mmHg, n ¼ 10; ovariectomized: 129.4 + 9.2 mmHg, n ¼ 12; P . 0.05), indicating that the alterations in vascular function to be shown later appears to be independent of blood pressure levels.
Expression of COX-1 and COX-2 protein
Western blot analysis showed that ovariectomy did not alter the expression of COX-1, whereas it increased the expression of COX-2 protein (Figure 1 ).
Vascular reactivity
The vasodilator response induced by ACh was similar in aortic segments from ovariectomized and control rats (ANOVA, P . 0.05; Table 1 ).
Incubation with the specific COX-2 inhibitor NS-398, (10 mmol/L, 30 min), decreased the ACh-induced response in aortas from control and ovariectomized rats (Figure 2) . Despite the absence of differences in the ACh-induced response, the contribution of products derived from COX-2 might be distinct. Therefore, the arteries were incubated with specific prostanoid synthase inhibitors or receptor blockers.
Pre-incubation with the TXA 2 synthase inhibitor, furegrelate (1 mmol/L, 30 min), did not modify the relaxation induced by ACh in segments from control or ovariectomized rats ( Figure 2A and B, Table 1 ). Pre-incubation with the TP receptor antagonist, SQ29,548 (1 mmol/L, 30 min), did not modify the response to ACh in arteries from control rats, whereas decreased the ACh-induced relaxation in arteries from ovariectomized rats (Figure 2A and B), in agreement with the increased EC 50 of ACh in presence of SQ29,548 only in arteries from ovariectomized rats ( Table 1) . Preincubation with the PGI 2 synthase inhibitor, TCP (10 mmol/L, 30 min), decreased ACh-induced relaxation more in arteries from ovariectomized rats than in those of control rats ( Figure 3, Table 1 ). Pre-incubation with TCP plus furegrelate, or TCP plus SQ29,548, normalized the ACh-induced response to control level in arteries from control rats ( Figure 3A) , while it was not normalized in arteries from ovariectomized rats ( Figure 3B , Table 1 ). The effects of the different drugs used on the maximum response (E max ) to ACh and the EC 50 are summarized in Table 1 .
These results suggest the existence of an additional prostanoid in arteries from ovariectomized rats whose vasoconstrictor action is not mediated through TP receptors activation. It was for this reason that the formation of PGI 2 , TXA 2 , PGF 2a , and PGE 2 was analysed, as well as their vasomotor effect.
The TXA 2 mimetic U-46619 (1 nmol/L to 10 mmol/L) induced a contractile response, which was increased in arteries from ovariectomized rats ( Figure 4A) . The vasodilator response induced by exogenous PGI 2 (0.1 nmol/L to 1 mmol/L) was decreased in arteries from ovariectomized rats with regard to those of control rats ( Figure 4B) . The contractile responses induced by exogenous PGF 2a or by exogenous PGE 2 (1 nmol/L to 10 mmol/L) were increased in arteries from ovariectomized rats ( Figure 4C and D) . The effect of ovariectomy on the E max to the exogenous prostanoids used and EC 50 are summarized in Table 2 .
Prostanoids production
Ovariectomy increased the ACh-stimulated aortic production of TXA 2 , 6-keto-PGF 1a , 13,14-dihydro-15-keto PGF 2a , and PGE 2 ( Table 3) . Pre-incubation with TCP plus furegrelate did not alter the ACh-induced PGE 2 formation in arteries from control rats, while enhanced that induced in arteries from ovariectomized rats ( Table 3) .
Prostanoids effect on no release
Basal and ACh-induced NO release was similar in aortas from both control and ovariectomized rats (ANOVA, P . 0.05), as previously reported. 17 In aortic segments from control rats, . Number of segments is indicated in parenthesis; number of animals used was 4-5 for control or ovariectomized rats. *P , 0.05, **P , 0.001 compared with control rats. pre-incubation with NS-398, (10 mmol/L) did not modify basal or ACh-induced NO release, whereas pre-incubation with furegrelate (1 mmol/L), TCP (10 mmol/L), or TCP plus furegrelate increased the ACh-induced NO release ( Figure 5A ). In contrast, in arteries from ovariectomized rats, pre-incubation with NS-398, furegrelate, TCP, or TCP plus furegrelate decreased the ACh-induced NO release ( Figure 5B ).
Discussion
The participation of different sex hormones on vascular tone regulation has been widely described. [24] [25] [26] However, the real changes on different signalling pathways that take place when the gonadal function is lost during long periods of time -as in menopause-, is still matter of study. In this regard, we have previously reported that ovariectomy 17 and orchidectomy 22 regulate the NO signalling pathway. We now provide evidence that ovariectomy also regulates the release and function of prostanoids derived from COX-2, indicating that complementary cell signalling pathways are simultaneously working to preserve vascular function.
The effects of ovariectomy on vascular function are not related to haemodynamic changes, since ovariectomy did not modify blood pressure, according to data previously reported, 27 and seem to be related to the loss of ovarian function as indicated by the observed uterine atrophy. 23 It is important to note that in human or animal models of menopause gain body weight is observed, especially due to adiposity; 23, 27 in this regard, the adipose tissue could be a source of hormones and cytokines which could influence vascular function, although loss of gonadal function is what induce these alterations.
In addition to NO, endothelial cells also release vasoconstrictor and vasodilator prostanoids that are involved in the modulation of vascular tone. 3, 27, 28 Since prostanoids are derived from COX-1 and COX-2, we analysed the possible differences in the expression of both isoforms induced by the loss of ovarian function. Ovariectomy did not modify the expression of COX-1, but it increased that of COX-2, although other studies have described that ovariectomy decreases COX-1 29 and COX-2 30 expression. One possible explanation could be that those studies compare ovariectomy vs. the specific effect of acute administration of estrogens in culture cells, whereas in our animal model, we compared the effect of ovariectomy vs. intact cycling rats, in which different ovarian hormones/factors are involved. 31 Additionally, it is known that the loss of ovarian function leads to an increased superoxide anion formation 17 that might induce COX-2 expression. 32 These results indicate that COX-2 derivatives could also be increased by ovariectomy and participate in the regulation of vascular function. Therefore, the effect of the COX-2 inhibitor NS-398 on the ACh-induced response was analysed. NS-398 decreased the ACh-induced relaxation in both groups of rats, apparently indicating the participation of vasodilator COX-2 derived products in that response. Since the action of endogenous prostanoids on neuronal NO release is under male sex hormone regulation, 15 we investigated the action of COX-2 derivates on NO release in both groups of rats. NS-398 did not modify the basal and ACh-induced NO release in aorta from control female, but it decreased those produced in aorta from ovariectomized rats, indicating that ovarian function regulates the action of endogenous prostanoids derived from COX-2 on NO release. This result shows that the inhibition of NO release is involved in the diminished ACh-induced response caused by NS-398 in aortas from ovariectomized rats and suggests the participation of vasodilator or vasoconstrictor prostanoids in the The effect of TCP (1 mmol/L) plus furegrelate (Fure, 1 mmol/L) on the ACh-induced PGE 2 production is also shown. Results (mean + SEM) are expressed as pg/mL mg tissue. n, number of arteries used (two per animal). *P , 0.05. **P , 0.001 vs. control rats. ACh-induced response in aortas from control or ovariectomized rats, respectively. TXA 2 is one of the most important vasoconstrictor prostanoids that can participate in endothelial dysfunction associated with different cardiovascular risk factors. [33] [34] [35] On the basis of our previous studies, 15, 36, 37 the production of TXA 2 was analysed. The ACh-induced TXA 2 formation was increased in aortas from ovariectomized rats, which is in line with the increased release of contractile prostanoids suggested in resistance arteries from ovariectomized rats. 27 The fact that furegrelate or SQ29,548 had no effect on the ACh response in arteries from control animals, indicates that TXA 2 did not participate in that response, as already reported. 9, 10 However, in arteries from ovariectomized rats, furegrelate did not modify the vasodilator response to ACh in spite the increased release of TXA 2 , suggesting possible alterations in the sensitivity to TXA 2 and/or that alternative routes are operational. The fact that the contractile response to the TXA 2 mimetic U-46619 was increased in arteries from ovariectomized rats, as already reported, 38 seems to contradict the results obtained with furegrelate, but is in line with the decreased ACh-induced relaxation in the presence of SQ29,548. These results indicate that when TXA 2 synthesis is inhibited the production of other factors, whose action is not mediated by TP receptors activation, could be increased.
Therefore, we investigated the effect of inhibiting PGI 2 synthesis on the ACh-induced response. TCP decreased the vasodilator response to ACh to a greater extent in arteries from ovariectomized than in those of control rats, which would indicate a greater involvement of this vasodilator prostanoid in the former arteries, possibly due to changes in PGI 2 synthesis and/or the vasomotor effect. The ACh-induced PGI 2 release was increased in arteries from ovariectomized rats, probably due to superoxide anion overproduction observed in aortas from ovariectomized rats, 17 supporting the concept of redox regulation of vascular prostanoid synthesis. 39 The fact that exogenous PGI 2 -induced relaxation was decreased in aorta from ovariectomized rats did not explain the significant decrease in the ACh-induced response in presence of TCP and suggest the involvement of other vasoactive factors. Since cross-talk between the PGI 2 and TXA 2 pathways have been reported, 15, 18 the effect of inhibiting the synthesis of both prostanoids was analysed. The co-incubation of arteries with TCP plus furegrelate, or TCP plus SQ29,548, normalized the ACh-induced response to control level in arteries from control rats, showing the existence of a balance between TXA 2 and PGI 2 in these arteries. However, in arteries from ovariectomized rats, the co-incubation with TCP plus furegrelate or plus SQ29,548 did not completely normalized the decreased ACh response caused by TCP. These results indicate the participation of prostanoids other than PGI 2 and TXA 2 that could induce contraction by activating receptors other than TP. Since the ACh-induced PGF 2a production and its vasoconstrictor effect were both very limited, the most plausible candidate for the first hypothesis could be PGE 2 . In fact, ACh-induced PGE 2 production was greater in arteries from ovariectomized than in those of control rats and that co-incubation with furegrelate plus TCP further increased it only in aorta from ovariectomized, probably as a consequence of increased PGH 2 production and subsequent transformation into PGE 2 . 40, 41 Although PGE 2 can induced vasoconstrictor and vasodilator response depending on vessel tone, 42 we analysed its vasoconstrictor effect, similar to that performed in orchidectomized rats. 18 We observed a greater PGE 2 -induced vasoconstrictor response in aortas from ovariectomized than in those from control rats, indicating that PGE 2 could be involved in the decreased ACh-induced relaxation in the presence of TCP plus Figure 6 Scheme showing the effect of ovariectomy on the ACh-induced relaxation. The scheme shows that ovariectomy increases COX-2 expression and that when ACh activates the muscarinic receptor (M-R) the release of prostaglandin (PG) I 2 , PGE 2 , PGF 2a , and thromboxane (TX) A 2 is induced; ovariectomy increases the ACh-induced release of PGI 2 , PGE 2 , and TXA 2 . Additionally, when the synthesis of PGI 2 and TXA 2 is inhibited with tranylcipromine (TCP) and furegrelate (Fure), respectively, the release of PGE 2 is increased, and ovariectomy increases that effect. These prostanoids through their respective specific receptors (IP-R, specific receptor for PGI 2 ; EP-R, specific receptors for PGE 2 ; FP-R, specific receptor for PGF 2a ; TP-R, receptor for TXA 2 and prostanoids) exert a net vasoconstrictor effect in ovariectomized rats. In turn, the increased formation of prostanoids derived from COX-2 positively regulates the eNOS activity only in aorta from ovariectomized rats. This mechanism could compensate for the decreased endothelial NO bioavailability 17 and it may contribute for the maintenance of the ACh-induced relaxation in aortas from ovariectomized rats. NS-398, specific COX-2 inhibitor; SQ29,548, TP-receptor antagonist.
furegrelate. It is important to note that the results found in aortas from ovariectomized rats regarding the release and function of prostanoids derived from COX-2 are essentially the same as that described in aortas from orchidectomized rats, 18 indicating that the loss of respective gonadal function, in males or female rats, induces an imbalance in the production and function of vasodilator and vasoconstrictor prostanoids, the latter being the predominant effect. Both pathophysiological conditions have in common disturbed redox equilibrium, since the formation of superoxide anion is increased in aortas from orchidectomized 22 and ovariectomized 17 rats, according to modulation of prostanoids synthesis by redox environment. 41, 43 In spite of this finding, the possibility of a decreased involvement of vasodilator factors cannot be ruled out. Since endogenous PGI 2 or/and TXA 2 could modulate the neuronal NO release, 13, 15 we analysed the release of NO when the synthesis of TXA 2 , PGI 2 , or both was inhibited. In arteries from control rats, furegrelate, TCP, or a combination of both inhibitors increased the ACh-induced NO release, in agreement with the inhibitory effect of prostanoids on endothelial, 44 inducible 45 and neuronal 15 NO release. The fact that the COX-2 inhibitor, NS-398 did not modify the NO release indicates that the prostanoids earlier mentioned are derived from COX-1, which support the constitutive condition of this isoform. 46 In contrast, in arteries from ovariectomized rats, the COX-2 inhibitor as well as the inhibitors of specific prostanoids decreased the ACh-induced NO release indicating a positive regulation of eNOS activity by prostanoids derived from COX-2. This effect could counterbalance the decreased NO bioavailability 17 and the predominance of vasoconstrictor prostanoids observed in aortas from ovariectomized rats, and it may be the responsible for the maintained ACh-induced response in aortas from ovariectomized rats ( Figure 6) . This is the first study showing that ovarian function regulates the effect of endogenous prostanoids on endothelial NO release in rat aorta. Additionally, this study demonstrates that ovariectomy enhances COX-2 expression, and induces an overproduction of vasoconstrictor prostanoids, that would ultimately increase blood pressure and decrease vasodilatory response. However, the upregulation of eNOS activity by COX-2 derived prostanoids could be involved in preventing those effects, although complementary cell signalling pathways-such as the NO-cGMP pathway and their targets-could be working simultaneously.
This intriguing information warrants further studies on different cell signalling pathways when the loss of ovarian function is maintained during long periods of time, as occurring in menopause.
